121 related articles for article (PubMed ID: 27073481)
1. Association between overexpression of Wip1 and prognosis of patients with non-small cell lung cancer.
Zhao M; Zhang H; Zhu G; Liang J; Chen N; Yang Y; Liang X; Cai H; Liu W
Oncol Lett; 2016 Apr; 11(4):2365-2370. PubMed ID: 27073481
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
[TBL] [Abstract][Full Text] [Related]
3. Proto-oncogene Wip1, a member of a new family of proliferative genes in NSCLC and its clinical significance.
Fu Z; Sun G; Gu T
Tumour Biol; 2014 Apr; 35(4):2975-81. PubMed ID: 24272082
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer.
Inoue Y; Yamashita N; Kitao H; Tanaka K; Saeki H; Oki E; Oda Y; Tokunaga E; Maehara Y
Clin Breast Cancer; 2018 Aug; 18(4):e643-e650. PubMed ID: 29275106
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic phosphatase Wip1 is a novel prognostic marker for lung adenocarcinoma patient survival.
Satoh N; Maniwa Y; Bermudez VP; Nishimura K; Nishio W; Yoshimura M; Okita Y; Ohbayashi C; Hurwitz J; Hayashi Y
Cancer Sci; 2011 May; 102(5):1101-6. PubMed ID: 21281403
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of Wip1 overexpression and its association with the p38MAPK/p53/p16 pathway in NSCLC.
Yang S; Dong S; Qu X; Zhong X; Zhang Q
Mol Med Rep; 2017 Feb; 15(2):719-723. PubMed ID: 27959454
[TBL] [Abstract][Full Text] [Related]
7. Wild-type p53-induced phosphatase 1 is a prognostic marker and therapeutic target in bladder transitional cell carcinoma.
Wang ZP; Chen SY; Tian Y
Oncol Lett; 2017 Feb; 13(2):875-880. PubMed ID: 28356972
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers.
Yu E; Ahn YS; Jang SJ; Kim MJ; Yoon HS; Gong G; Choi J
Breast Cancer Res Treat; 2007 Mar; 101(3):269-78. PubMed ID: 16897432
[TBL] [Abstract][Full Text] [Related]
9. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
10. p53-Independent expression of wild-type p53-induced phosphatase 1 (Wip1) in methylmethane sulfonate-treated cancer cell lines and human tumors.
Park JY; Song JY; Kim HM; Han HS; Seol HS; Jang SJ; Choi J
Int J Biochem Cell Biol; 2012 Jun; 44(6):896-904. PubMed ID: 22405851
[TBL] [Abstract][Full Text] [Related]
11. Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma.
Fuku T; Semba S; Yutori H; Yokozaki H
Pathol Int; 2007 Sep; 57(9):566-71. PubMed ID: 17685927
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of periostin predicts poor prognosis in non-small cell lung cancer.
Hong LZ; Wei XW; Chen JF; Shi Y
Oncol Lett; 2013 Dec; 6(6):1595-1603. PubMed ID: 24273600
[TBL] [Abstract][Full Text] [Related]
13. Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer.
Cheng YL; Lee SC; Harn HJ; Chen CJ; Chang YC; Chen JC; Yu CP
Eur J Cardiothorac Surg; 2003 Feb; 23(2):221-8. PubMed ID: 12559346
[TBL] [Abstract][Full Text] [Related]
14. Wip1: A candidate phosphatase for cancer diagnosis and treatment.
Oghabi Bakhshaiesh T; Majidzadeh-A K; Esmaeili R
DNA Repair (Amst); 2017 Jun; 54():63-66. PubMed ID: 28385459
[TBL] [Abstract][Full Text] [Related]
15. WIP1 phosphatase as a potential therapeutic target in neuroblastoma.
Richter M; Dayaram T; Gilmartin AG; Ganji G; Pemmasani SK; Van Der Key H; Shohet JM; Donehower LA; Kumar R
PLoS One; 2015; 10(2):e0115635. PubMed ID: 25658463
[TBL] [Abstract][Full Text] [Related]
16. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.
Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
[TBL] [Abstract][Full Text] [Related]
17. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
[TBL] [Abstract][Full Text] [Related]
18. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
[TBL] [Abstract][Full Text] [Related]
19. WIP1 stimulates migration and invasion of salivary adenoid cystic carcinoma by inducing MMP-9 and VEGF-C.
Tang YL; Liu X; Gao SY; Feng H; Jiang YP; Wang SS; Yang J; Jiang J; Ma XR; Tang YJ; Chen Y; Liang XH
Oncotarget; 2015 Apr; 6(11):9031-44. PubMed ID: 25797250
[TBL] [Abstract][Full Text] [Related]
20. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
